Skip to main content
Marinus Pharmaceuticals, Inc. (MRNS)
NASDAQ: MRNS · IEX Real-Time Price · USD
1.430
+0.040 (2.88%)
At close: Jul 19, 2024, 4:00 PM
1.320
-0.110 (-7.69%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Marinus Pharmaceuticals Revenue

Marinus Pharmaceuticals had revenue of $28.29M in the twelve months ending March 31, 2024, with 30.53% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.68M. In the year 2023, Marinus Pharmaceuticals had annual revenue of $30.99M with 21.63% growth.

Revenue (ttm)
$28.29M
Revenue Growth
+30.53%
P/S Ratio
2.78
Revenue / Employee
$170,410
Employees
166
Market Cap
78.55M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202330.99M5.51M21.63%
Dec 31, 202225.48M10.13M66.03%
Dec 31, 202115.35M13.63M793.19%
Dec 31, 20201.72M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 2012100.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PetMed Express 281.06M
Forian 20.49M
T2 Biosystems 7.18M
Affimed 4.26M
Nutriband 2.02M
Revenue Rankings

MRNS News

More News